| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |